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Phosphoinositide 3-Kinase  Is an Essential
Amplifier of Mast Cell Function
displayed on the  and  subunits are phosphorylated
by the protein tyrosine kinase Lyn and the subsequently
recruited Syk. Class IA PI3Ks, which are defined as such
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and Matthias P. Wymann1,4 by their tight association with a regulatory p85-like
subunit containing two src homology-2 domains (SH2)1Institute of Biochemistry
Department of Medicine (for a review on PI3Ks see Wymann and Pirola [1998]),
recognize phosphorylated ITAMs as docking sites.University of Fribourg
Rue du Muse´e 5 PtdIns(3,4,5)P3, the product of PI3K, is absolutely re-
quired for the initiation of a signaling cascade involvingCH-1700 Fribourg
Switzerland Bruton’s tyrosine kinase (Btk) and phospholipase C,
which culminates in the opening of plasma membrane2 Novartis Respiratory Research Centre
Wimblehurst Road calcium channels and granule release. PtdIns(3,4,5)P3
levels are, however, downregulated by the action of theHorsham, West Sussex RH12 5AB
United Kingdom SH2-containing inositol 5-phosphatase (SHIP), which
limits FcRI-mediated mast cell responses (for a review3 Dipartimento di Genetica, Biologia e Biochimica
Universita` di Torino see Turner and Kinet [1999]).
In contrast to the well-established role of PI3K down-Via Santena 5bis
I-10126 Torino stream of FcRI, the GPCR-derived signals driving mast
cell activation have not been identified. The fact thatItaly
bronchial hyperreactivity in asthmatics is induced by
inhalation of adenosine in atopic but not normal patients,
on the other hand, illustrates the cooperation of GPCRSummary
and FcRI signaling in disease. Adenosine, released by
various cells including mast cells during ischemia, in-Mast cells are key regulators in allergy and inflamma-
tion, and release histamine upon clustering of their IgE flammation, and in damaged tissue, activates mast cells
and renders them hyperreactive to allergen/IgE com-receptors. Here we demonstrate that murine mast cell
responses are exacerbated in vitro and in vivo by auto- plexes. Maximal mast cell activation leads to systemic
effects, such as smooth muscle contraction, mucus se-crine signals through G protein-coupled receptors
(GPCRs) and require functional phosphoinositide 3-kin- cretion, increase in vascular permeability, and finally the
recruitment of other inflammatory cells (for a review seease  (PI3K). Adenosine, acting through the A3 aden-
osine receptor (A3AR) as well as other agonists of Forsythe and Ennis [1999]). Although four known adeno-
sine receptors have been studied thoroughly and canGi-coupled GPCRs, transiently increased PtdIns(3,4,5)P3
exclusively via PI3K. PI3K-derived PtdIns(3,4,5)P3 be targeted pharmaceutically in rats and humans, down-
stream events mediating the exacerbation of adenosinewas instrumental for initiating a sustained influx of
external Ca2 and degranulation. Mice lacking PI3K and other GPCR ligands on mast cell hyperreactivity
remain to be elucidated.did not form edema after intradermal injection of aden-
osine and when challenged by passive systemic ana- Among the different PI3K isoforms, phosphoinositide
3-kinase  (PI3K, a class IB PI3K not interacting withphylaxis. PI3K thus relays inflammatory signals
through various Gi-coupled receptors and is central p85-like subunits) was shown to be activated by 
subunits of trimeric G proteins (Stoyanov et al., 1995;to mast cell function.
Stephens et al., 1997). We have reported recently, that
PI3K plays an important role in the recruitment of neu-Introduction
trophils and macrophages to inflammatory sites (Hirsch
et al., 2000). Here we show that the absence of PI3KMast cells reside in tissues and are primary effector
cells initiating the allergic and inflammatory cascade. disrupts Gi protein-coupled signaling, mast cell degran-
ulation in vitro, and protects animals from edema forma-Through their high-affinity IgE receptor (FcRI), mast
cells are linked to atopy and acquired immunity. On the tion induced by adenosine and by passive systemic
anaphylaxis. Our finding that PI3K processes signalsother hand, their G protein-coupled receptors (GPCRs)
relay signals derived from complement activation (C5a from many Gi protein-coupled receptors—to produce a
pulse of PtdIns(3,4,5)P3 that circumvents the control ofand C3a), tissue damage, inflammation, and ischemia
(e.g., adenosine and chemokines), placing the mast cell SHIP—attributes to this PI3K isoform a novel key func-
tion in mast cell activation and in the control of allergicat the center of innate immune defense and chronic
inflammatory processes (Metcalfe et al., 1997). and inflammatory processes at their very beginning.
Mast cell activation is achieved by antigen/IgE-medi-
ated cross-linking of the FcRI receptor. The FcRI is Results
composed of an  chain ligating the Fc part of IgE, two
, and an optional  chain. Upon  chain cross-linking, PI3K/ Mast Cells Show Reduced Responsiveness
immunoreceptor tyrosine-based activation motifs (ITAMs) to FcRI Cross-Linking
Release of histamine-containing granules from mast
cells is triggered in response to clustering of their high-4 Correspondence: matthias.wymann@unifr.ch
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affinity receptor for IgE, FcRI, and involves a protein variety of secondary stimuli (Marquardt et al., 1978;
Hughes et al., 1984; Peachell et al., 1991; Ramkumar ettyrosine kinase cascade and the recruitment of the class
IA heterodimeric p85/p110 PI3Ks (for a review see al., 1993). And indeed, 65% of the PI3K-dependent part
of the IgE/antigen-induced response could be elimi-Turner and Kinet [1999]). To evaluate the possibility if
PI3K, which does not associate with the p85 adaptor nated by adenosine deaminase (Figure 1E), which con-
verts adenosine to inosine, a low-affinity ligand forsubunit, could contribute to the antigen-induced mast
cell activation, bone marrow-derived mast cells (BMMC) adenosine receptors. B. pertussis toxin pretreatment,
resulting in the inactivation of Gi proteins by ADP-ribosy-from wild-type and PI3K-deficient mice (Hirsch et al.,
2000) were incubated with IgE directed against dinitro- lation, did the same (59% reduction). This suggested
that adenosine contributes to autocrine signaling viaphenol-modified human serum albumin (DNP-HSA) and
subsequently stimulated by the addition of the experi- G proteins. To further explore the possibility whether
adenosine initiated a PI3K-dependent sensitization ofmental allergen DNP-HSA. Mast cell granule release was
assessed by the activity of -hexosaminidase, a marker mast cells, wild-type and PI3K/ BMMC were chal-
lenged with IgE, antigen, and adenosine in parallel.enzyme for histamine-containing granules, and was in-
creasingly stimulated by elevated allergen concentra- At antigen concentrations up to 5 ng/ml, where wild-
type and PI3K null mast cells displayed equal granuletions. At concentrations of antigen below 5 ng/ml, wild-
type and PI3K/ BMMC released equal amounts of release responses to IgE/antigen, low concentrations of
adenosine (0.1 M) doubled the release of -hexos--hexosaminidase (Figure 1A; p  0.05). When DNP-
HSA concentrations were further increased, however, aminidase in wild-type, but did not further stimulate mu-
tated BMMC (Figure 2A). When adenosine levels werewild-type BMMC released up to 55% of their total gran-
ule contents, while cells without PI3K did not release increased by 10- to 100-fold (to 1–10 M), however,
PI3K null cells started to respond partially. Varying anti-more than 30%. Sustained elevations in cytosolic cal-
cium concentrations ([Ca2	]i) paralleled this pattern (bars gen (1–10 ng/ml) and adenosine concentrations (0.1–10
M) at the same time, it became clear that the adenosinein Figure 1A).
As there is no rationale for a direct interaction of the costimulatory signal was fully dependent on the pres-
ence of functional PI3K at low concentrations of eitherFcRI system with trimeric G protein signaling and
PI3K, we evaluated whether mast cell-derived factors stimulus but could reach about 50% of the wild-type
signal when both allergen and adenosine where maximalstimulated an autocrine pathway independent of FcRI.
In time course studies of the granule release response, (Figure 2B). These results demonstrate that at low aden-
osine or antigen concentration, the costimulatory signalwild-type and PI3K null cells displayed identical secre-
tion kinetics up to 5 min, but at later times signal traces requires PI3K, while the nature of the compensating
mechanisms at higher stimulus concentration needs fur-departed from each other to reach the maximal levels
mentioned above for each genotype (Figure 1B). This ther investigation to be identified.
discrepancy suggests that the late phase of the release
response was augmented by constituents liberated by PI3K Links Adenosine Receptor to Plasma
the mast cells themselves. This view was also supported Membrane Calcium Influx
by the fact that the granule release of wild-type cells To investigate the role of PI3K in signaling events lead-
was augmented when-hexosaminidase release assays ing to mast cell degranulation, we measured calcium
were carried out at elevated cell concentrations (Figure mobilization in wild-type and PI3K null BMMC. FcR
1C), while high cell densities did not significantly in- or adenosine-dependent transient calcium rises initially
crease the responsiveness of PI3K null BMMCs. involve calcium mobilization from intracellular stores,
To determine if the above difference was due to but sustained calcium fluxes as required for degranula-
PI3K-dependent mast cell differentiation defects, pro- tion depend on the opening of plasma membrane chan-
liferation and mast cell surface markers were monitored nels (Scharenberg and Kinet, 1998). In mutant BMMC,
in wild-type and mutant BMMC. Cells from wild-type the lack of PI3K did not affect neither the adenosine-
and PI3K/ bone marrow proliferated equally well in induced transient release of calcium from internal stores
in vitro cultures supplied with IL-3 (data not shown). (Figure 2C, insert) nor the prolonged increase in cyto-
Markers of differentiated BMMC, like the high-affinity solic calcium concentration ([Ca2	]i) directly mediated
IgE receptor (FcRI) and c-Kit, were equally expressed by IgE and low concentrations of DNP-HSA (Figure 1A,
in cells of both genotypes (Figure 1D). This illustrates 5 ng/ml DNP-HSA; and Figure 2D, upper panel). Com-
that mast cell proliferation and differentiation were not bined at an interval of 1 min, adenosine and IgE/antigen
impaired by the loss of PI3K as assessed by these triggered a steady elevation of the cytosolic calcium
criteria. concentration (M). Calcium entered the cells through
plasma membrane channels, as extracellular EGTA and
Mn2	 quenched this part of the response (data notAbsence of Adenosine-Mediated Hyperreactivity
in PI3K/ Mast Cells shown). This synergy (as well as -hexosaminidase re-
lease) (data not shown) was equal in amplitude irrespec-Upon antigen-mediated stimulation, mast cells release
a variety of mediators like adenosine, histamine, seroto- tive of the sequence in which stimuli were added (Fig-
ures 2C and 2D, lower panel). In contrast, no synergisticnin, and lipid mediators that could potentially interact
with GPCRs on their surface. Of these agonists, adeno- effect of adenosine and IgE/DNP-HSA stimulation was
observed in the absence of PI3K (Figures 2C and 2D,sine was reported to be produced by activated mast
cells (Marquardt et al., 1986; Lloyd et al., 1998) and was lower panel).
To verify whether PI3K function interfered with ex-shown to enhance mediator release in response to a
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Figure 1. Mast Cell Degranulation by IgE/
Antigen Stimulation Is Modulated by a PI3K-
Dependent Pathway
(A) Granule release was followed by -hex-
osaminidase activity in wild-type (wt) and
PI3K/ BMMC previously incubated with
saturating levels of IgE. Cells (106/ml) were
stimulated for 20 min with the indicated
amount of DNP-HSA before -hexosaminidase
was assessed in the cell supernatant. Bars
represent intracellular calcium summed up
over 4 min. Values are expressed in arbitrary
units.
(B) Granule release as in (A) was measured
after exposure to 10 ng/ml DNP-HSA for the
indicated times.
(C) Granule release was assessed at the indi-
cated cell densities after stimulation with 10
ng/ml DNP-HSA for 20 min. Values are means
of more than four experiments 
 SEM. Error
bars were omitted where smaller than sym-
bols. Stars indicate significant differences
between genotypes (p  0.005).
(D) Cell surface expression of the high-affinity
IgE receptor (IgE-R) and c-Kit in BMMC from
wild-type and PI3K/ mice were assessed
by FACS. Dotted lines represent control sig-
nals obtained with isotype matched antibody
or GM-CSF differentiated bone marrow-
derived monocytes. Solid lines show elevated
expression of IgE-R and c-Kit in 4-week-old
IL-3-differentiated BMMC cultures.
(E) Mast cells were preincubated without ()
or with (	) adenosine deaminase (ADA) or B.
pertussis toxin (PTx) before DNP-HSA (10 ng/
ml) was added. Release is depicted as differ-
ence between wild-type (wt) and PI3K/, in
relation to the wild-type response. Bars thus
directly reflect the part of the response that
is dependent on PI3K, and % values indicate
the fraction resistant to the indicated
treatment.
pression levels of the adenosine signaling machinery, a prominent transient increase of the lipid messenger
in wild-type BMMC, while mutant cells did not respondwe assessed the presence of adenosine receptors of
type A1, A2a, A2b and A3 in wild-type and mutant BMMC. (Figure 3A). Likewise, protein kinase B (PKB) phosphory-
lation—an event strictly depending on PtdIns(3,4,5)P3In both genotypes, all receptors were equally expressed,
as were the heterotrimeric G protein subunits Gi2 and synthesis—was absent in PI3K null BMMC and could
not be rescued by elevated adenosine concentrationsGi3 (Figure 2E). Together with the fact that loss of PI3K
did not affect the adenosine-triggered transient rise in (100 M). IL-3 and SCF (stem cell factor, c-kit ligand),
on the other hand, elicited PKB activation in wild-type[Ca2	]i, this suggests that no GPCR signaling elements
other than PI3K were impaired. and the PI3Knull genotype, illustrating that p85-associ-
ated (class IA) PI3K signaling pathways were intact (Fig-It is thus likely that activated PI3K takes part in mast
cell calcium signaling and degranulation by the delivery ure 3F). This clearly demonstrates an exclusive coupling
of PI3K to adenosine receptors without the involvementof PtdIns(3,4,5)P3 in response to adenosine stimulation.
We therefore evaluated PtdIns(3,4,5)P3 synthesis and of other PI3K isoforms, which is in agreement with find-
ings made for chemokine receptors in neutrophils andcalcium mobilization as interconnected processes in
wild-type and PI3K null BMMC. The analysis of macrophages (Hirsch et al., 2000).
Wortmannin, a PI3K inhibitor targeting a broad rangePtdIns(3,4,5)P3 in adenosine-stimulated BMMC showed
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Figure 2. Adenosine-Mediated Hyperreactivity of Mast Cells Is PI3K Dependent
Granule release (A and B) and intracellular calcium contrentrations [Ca2	]i (C and D) were measured in wild-type (wt) and PI3K/ BMMC
saturated with IgE.
(A) Cells were stimulated with or without adenosine for 1 min, before 5 ng/ml of DNP-HSA (DNP) was added for 20 min.
(B) Adenosine and DNP-HSA concentrations were varied as indicated, and the difference between the DNP-HSA response with or without
adenosine is shown (n  4; mean 
 SEM).
(C) [Ca2	]i was determined while adenosine and DNP-HSA (DNP) were added sequentially.
(D) Upper panel, BMMC as in (C) were stimulated by DNP-HSA only. Lower panel, adenosine was added after DNP-HSA (all representative
for n  3).
(E) BMMC were subjected to immunoblotting with antibodies against the A1, A2a, A2b, and A3 adenosine receptors, and Gi2 and Gi3 proteins.
of PI3K isoforms (for a review see Wymann and Pirola and 3E) for a prolonged time. The preaddition of adeno-
sine (by 1 min) elevated PtdIns(3,4,5)P3 levels to 20-[1998]), has been reported before to block histamine re-
lease from IgE/allergen-stimulated mast cells (Yano et al., fold over background in wild-type, but not in PI3K null
BMMC. This elevation was transient and returned to IgE/1993; Marquardt et al., 1996). Here, wortmannin left the
adenosine-mediated calcium increase unaffected, but DNP-HSA-induced levels within 5 min. Phosphorylation
of PKB on Ser473 followed PtdIns(3,4,5)P3 production:reduced the costimulatory FcRI-dependent signal dra-
matically (Figure 3B). It is interesting to note that the IgE/allergen stimulation produced a faint but significant
signal in both genotypes, and adenosine costimulationinhibition of all PI3K isoforms did reduce [Ca2	]i to the
level detected in PI3K null BMMC, suggesting that produced a strong signal in wild-type cells, while PI3K
null BMMC did not respond (Figure 3F). These data sug-plasma membrane channel opening under costimulatory
conditions is exclusively promoted by PtdIns(3,4,5)P3 de- gest that the amplifying effect of adenosine, which leads
to maximal calcium influx and -hexosaminidase release,rived from PI3K. Wortmannin also abolished the release
of-hexosaminidase in response to IgE/DNP-HSA alone strictly requires a PI3K-dependent PtdIns(3,4,5)P3 pro-
duction. A single short, transient pulse of PtdIns(3,4,5)P3(Yano et al., 1993; Marquardt et al., 1996) or in combina-
tion with adenosine, which is in agreement with the no- succeeding a threshold set above the long-term produc-
tion rate of the FcRI/class IA PI3K system thus seemstion that the inhibitor eliminates the FcRI/class IA PI3K
and the adenosine receptor/PI3K-mediated PtdIns sufficient to trigger augmented mast cell respon-
siveness.(3,4,5)P3 production (Figure 3C).
To test if the attenuated responses observed in mutant
BMMC were indeed caused by a lack of PtdIns(3,4,5)P3 Trimeric Gi Proteins Mediate Mast
Cell Hyperreactivityproduction even after combined stimulation with adeno-
sine and IgE/allergen, PtdIns(3,4,5)P3 was measured in Because adenosine binds to several distinct receptors
that are linked to different G isoforms, we investigatedcells treated with both stimuli. Activation of IgE-decor-
ated mast cells with allergen alone caused a 6-fold in- whether PI3K activity was coupled to a specific G pro-
tein in mast cells. Using B. pertussis toxin, calcium re-crease of PtdIns(3,4,5)P3 over background (Figures 3D
Phosphoinositide 3-Kinase  Essential in Mast Cells
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Figure 3. PtdIns(3,4,5)P3 and PKB Activation Levels Correlate with Mast Cell Hyperreactivity
(A, D, and E) PtdIns(3,4,5)P3 (PIP3) production was measured in BMMC metabolically labeled with 32Pi.
(A) Cells were stimulated with 1 M adenosine for the indicated time before PIP3 was quantified as in (D).
(B) Intracellular calcium concentration was followed in PI3K/ and wild-type (wt) BMMC saturated with IgE subsequently stimulated with adenosine
and DNP-HSA (5 ng/ml). Indicated in gray are responses of PI3K/ and wild-type BMMC preincubated with 100 nM wortmannin (Wm).
(C) -hexosaminidase release was measured in BMMC stimulated as in (B). Hatched bars reflect BMMC preincubated with 100 nM wortmannin.
(D) 32Pi-labeled BMMC preexposed to IgE were incubated with or without adenosine for 1 min before DNP-HSA (5 ng/ml) was added for the
indicated time. HPLC traces from deacylated lipids are shown; “4,5” refers to PtdIns(4,5)P2; “3,4,5” refers to PtdIns(3,4,5)P3.
(E) Peaks as in (D) corresponding to PtdIns(3,4,5)P3 were quantified and results expressed in cpm (n  3; mean 
 SEM). Hatched bars
represent stimulation with adenosine 1 min prior to DNP-HSA addition.
(F) Upper panel, BMMC were stimulated as in (E, ramp reflects increasing time of stimulation) and subjected to immunoblotting with anti-
phospho PKB (Ser-473) or anti-PKB, while the lower panel shows stimulations with stem cell factor (SCF, 100 nM, 1 min) and IL-3 (10 ng/ml,
5 min.).
lease from internal stores was only partially reduced gest that the adenosine-dependent hyperreactivity of
BMMC is mainly mediated by the A3 adenosine receptor,(Figure 4A, insert), suggesting a mixed coupling of the
combined adenosine receptors to Gi and Gq proteins that this receptor utilizes trimeric Gi proteins to activate
PI3K, and that PI3K then produces the pulse of(Forsythe and Ennis, 1999).
Treatment with B. pertussis toxin revealed, however, PtdIns(3,4,5)P3 which is indispensable for triggering a
maximal release of histamine-containing granules.that the adenosine/antigen-induced influx of extracellu-
lar calcium was entirely dependent on Gi-coupled recep- Moreover, the fact that B. pertussis toxin reduces the
calcium response of treated wild-type cells approxi-tors: in wild-type cells the toxin reduced the response
to the negligible levels found in PI3K null BMMC (Figure mately to the levels of untreated PI3K null cells, under-
lines that PI3K is the major relay of the A3AR signal to4A). When a specific A3 adenosine receptor (A3AR) ago-
nist, N6 -(3-iodobenzyl)-adenosine-5-N-methylcarbox- calcium influx and degranulation.
Adenosine is, however, not the sole ligand to augmentamide (IB-MECA), was used to stimulate mast cells,
both the initial calcium release from internal stores and allergen-dependent mast cell degranulation (Alam et al.,
1992, 1994; Conti et al., 1995). We show here that manythe subsequent costimulatory influx were completely
blocked by the action of B. pertussis toxin (Figure 4B). GPCR agonists potentially liberated during tissue dam-
age and anaphylactic shock can induce similar effects.This is in agreement with a preferential coupling of A3AR
to Gi (Palmer et al., 1995; Zhou et al., 1992). At the same Inosine, ATP, ADP, and LPA (data not shown), and the
chemokines MIP-1 and RANTES amplified allergen-time, B. pertussis toxin prevented the activation of PKB
by adenosine (Figure 4A, right panel) and IB-MECA (Fig- dependent granule release (Figure 5A) and calcium in-
flux (Figure 5D). All these responses required functionalure 4B, right panel), as well as the amplification of the
granule release response by agonists in combination PI3K, were B. pertussis toxin sensitive (data not
shown), and correlated with a PI3K-dependent activa-with allergen (Figure 4C). In summary, these data sug-
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Figure 4. Adenosine-Mediated Hyperreactiv-
ity of Mast Cells Occurs via Gi Proteins
(A) Left panel, intracellular calcium concen-
tration was followed in IgE-sensitized
PI3K/ and wild-type BMMC while they
were stimulated with adenosine and subse-
quently with DNP-HSA. Gray lines represent
traces of cells preincubated with 100 ng/ml
B. pertussis toxin for 4 hr. Right panel, wild-
type BMMC were incubated with B. pertussis
toxin before stimulation with adenosine and
detection of activated PKB (P-PKB).
(B) IB-MECA, a specific A3AR receptor ago-
nist was used as a stimuli in experiments set
up as in (A) (representative for n  3).
(C) -hexosaminidase was determined in IgE-
decorated PI3K/ and wild-type BMMC
stimulated with adenosine or IB-MECA be-
fore DNP-HSA was added 1 min later (n  3;
mean 
 SEM). Hatched bars represent the
response of BMMC pretreated with B. pertus-
sis toxin.
tion of PKB (Figure 5B). Platelet activating factor (PAF), sine (Tilley et al., 2000). Strikingly, adenosine did not
induce edema as measured by Evans blue leakage inon the other hand, activated PKB only to a very minor
extent, triggered calcium release from internal stores in PI3K null mice (Figure 6A; p  0.001 by Student’s t
test).a B. pertussis toxin-resistant fashion (Figure 5C), and
was not capable of acting synergistically with allergen We reported before that neutrophils and macro-
phages failed to migrate into infected and inflamed areasto advance granule release and external calcium influx
(Figure 5). This suggests that mast cell hyperreactivity is in PI3K null mice (Hirsch et al., 2000), and lower num-
bers of tissue mast cells might thus have been a reasonmediated only by seven transmembrane helix receptors
coupled to Gi proteins, which in turn activate PI3K to for a diminished responsiveness to adenosine. When
mast cells were quantified in the ear, skin, and tongueprovide PtdIns(3,4,5)P3, facilitating the allergen-depen-
dent granule release. of wild-type and PI3K null animals, however, no signifi-
cant differences in tissue mast cell numbers could be
detected (Table 1). The absence of the adenosine-Cutaneous and Passive Systemic Anaphylaxis
As mast cell hyperreactivity was dependent on PI3K dependent vascular permeabilization in PI3K null ani-
mals—and preliminary data showing that the responsein vitro, we examined the in vivo effects of the lack
of PI3K in a model of adenosine-induced mast cell can be reconstituted by the transfer of wild-type mast
cells into PI3Knull recipients (E.H., unpublished data)—activation. As previously described (Tilley et al., 2000),
intradermal injection of adenosine alone into the pinna illustrates that tissue mast cells depend on PI3K for
the initiation of edema formation.of the mouse ear causes a rise in microvascular perme-
ability. This response is specifically mediated by mast It has been previously shown that activation of mast
cells by FcRI receptor cross-linking can trigger a sys-cells, because mice devoid of functional mast cells
(W/WV mice) fail to elicit edema after injection of adeno- temic anaphylactic response (Dombrowicz et al., 1993).
Phosphoinositide 3-Kinase  Essential in Mast Cells
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Figure 5. Mast Cell Hyperreactivity Is Not Restricted to Adenosine, but Is Triggered by Other Gi Protein-Coupled Receptor Agonists through PI3K
(A) -hexosaminidase release in IgE-sensitized BMMC (wild-type, black bars; PI3K/, empty bars) stimulated with DNP-HSA for 1 min
followed by adenosine (1 M), MIP-1 (10 nM), RANTES (10 nM), or PAF (1 M) is shown.
(B) Total lysates from PI3K/ and wild-type BMMC stimulated for 1 min with the indicated agonists were analyzed for the presence of
activated PKB (P-PKB) or total PKB.
(C) Calcium release from internal stores was measured in wild-type BMMC preincubated with (gray) or without (black) B. pertussis toxin before
stimulation with platelet activation factor (PAF).
(D) Intracellular calcium concentrations were determined in BMMC stimulated as in (A). Results shown are representative of at least three
experiments each.
Passive immunization with mouse IgE followed by intra- of inflammatory mediators. Through their capacity to
release agonists that amplify inflammatory and allergicvenous injection of the corresponding antigen causes
pronounced plasma leakage and shock (Dombrowicz et reactions in the surrounding tissue, their activation sta-
tus is central to the initiation and the progress of theal., 1993; Tilley et al., 2000). We thus evaluated whether
the phenotypes displayed by PI3K null mast cells could local and systemic inflammatory cascade. We show here
in vitro and in vivo that PI3K is an important modulatorinfluence the course of such a systemic anaphylactic
response by concomitant injection of Evans blue and of this cascade, which has not been considered before.
A role of PI3K in mast cell degranulation, on the otherantigen into passively immunized mice. After adminis-
tration of IgE and antigen, vascular permeability in- hand, was demonstrated earlier using the potent, but
nonisoform-specific PI3K inhibitor wortmannin, whichcreased by more than 2-fold (Figures 6B and 6C; p 
0.001 by ANOVA) in wild-type mice. In contrast, pas- completely blocked FcRI-mediated mast cell degranu-
lation (Yano et al., 1993; Barker et al., 1995). Moreover,sively immunized and antigen-challenged PI3K null
mice did not show any edema formation, and Evans the FcRI  chain (Turner and Kinet, 1999; Wilson et al.,
2001), the linker for activation of T cells (LAT) (Zhang etblue in the tissue remained at the levels detected in
mice receiving antigen and Evans blue without prior al., 1998; Saitoh et al., 2000), and Grb2 binding protein
2 (Gab2) (Gu et al., 2001) have been shown to be associ-passive immunization (Figure 6B).
Altogether, the above in vitro and in vivo results are ated with PI3K activity and to be essential for FcRI-
induced mast cell degranulation and function. Thesecompatible with the hypothesis that mast cells activated
by FcRI cross-linking release a small part of their granules molecules provide docking sites for the p85-associated
PI3Ks, and it was suggested that the catalytic PI3K sub-and that granule contents subsequently act on GPCRs to
reinforce the IgE/antigen response. This amplification of units p110 and p110, but not p110, modulate FcRI-
dependent mast cell activation (Smith et al., 2001).mast cell degranulation appears essential for normal mast
cell function and depends on functional PI3K. Stimulation of class IA PI3Ks and production of
PtdIns(3,4,5)P3 is constantly counteracted by SHIP when
it is recruited to ITAM or immunoreceptor tyrosine-Discussion
based inhibition motifs (ITIM) (Ono et al., 1996; Osborne
et al., 1996; Kimura et al., 1997; Huber et al., 1998a;Mast cells are located in the noninflamed tissue and are
stimulated by immune complexes and a wide variety Scharenberg and Kinet, 1998). As a consequence, dis-
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it has been known long since that the activation of mast
cells by IgE and antigen can be dramatically potentiated
by adenosine (Marquardt et al., 1978). The relevance of
adenosine in allergic disease has also been demon-
strated pharmacologically (Forsythe and Ennis, 1999)
and with mice lacking adenosine deaminase. In the latter
accumulation of adenosine promotes chronic inflamma-
tion in the lung (Zhong et al., 2001). Despite reports that
the response to adenosine was sensitive to B. pertussis
toxin and that G proteins were involved in mast cell
degranulation (Gomperts, 1983; Marquardt and Walker,
1988), the nature of the GPCR downstream signaling
has remained obscured to date.
We demonstrate here that PI3K is the major relay
between adenosine receptor signaling and mast cell
degranulation. The lack of PI3K leaves the adenosine-
mediated calcium release from internal stores intact but
eliminates the costimulatory potential of adenosine to
cause massive influx of external calcium in IgE/antigen-
primed mast cells. Our results demonstrate that adeno-
sine even at high concentrations activates, of all PI3KFigure 6. Vascular Leakage after Intradermal Adenosine Injection and
Passive Systemic Anaphylaxis in Wild-Type but Not PI3K Null Mice isoforms, PI3K exclusively, which provides a transient
(A) Wild-type (black bars) and PI3K null mice (open bars) injected increase in PtdIns(3,4,5)P3. Although the adenosine-
with Evans blue were challenged by intradermal adenosine adminis- induced pulse of PtdIns(3,4,5)P3 production is short-
tration or vehicle. Vascular leakage of Evans blue was quantified lived and has a peak height of three to four times the
after extraction from tissue by OD at 610 nm. Data are mean differ- FcRI stimulation alone, it is sufficient to supersede a
ences (
SEM, n  6) of adenosine and saline-treated ears in each
putative threshold to cause massive opening of plasmaanimal.
membrane calcium channels. In BMMC, the FcRI-acti-(B) Passive systemic anaphylaxis. DNP-HSA and Evans blue were
injected into wild-type (black bars) and PI3K null mice (white bars), vated protein tyrosine kinase cascade must be activated
with (hatched bars) or without (filled hatched bars) prior systemic at the same time, as adenosine alone does not trigger
administration of anti-DNP-HSA IgE. Edema were quantified as in external calcium influx and degranulation by itself. PI3K
(A). Means of OD 610 nm (
SEM, n  7). is thus required for the induction but not for the mainte-
(C) Evans blue leakage in front paws of mice stimulated as in (B).
nance of the external calcium influx. Including observa-
tions made in SHIP null mice (Huber et al., 1998b), which
display elevated PtdIns(3,4,5)P3 levels, enforced calciumruption of the SHIP gene elevates PtdIns(3,4,5)P3 levels
influx and degranulation responses, but no changes inand renders mast cells hyperreactive (Huber et al.,
inositol(1,4,5)-trisphosphate concentrations, it is tempt-1998a, 1998b).
ing to speculate that the PI3K-derived PtdIns(3,4,5)P3In contrast to the class IA PI3Ks above, PI3K does
bypasses SHIP and might directly act on plasma mem-not interact with p85 and was proposed to be activated
brane calcium channels, as this was proposed for exog-by  subunits of trimeric G proteins (Stoyanov et al.,
enously added PtdIns(3,4,5)P3 (Ching et al., 2001).1995; Stephens et al., 1997). Moreover, PI3K was
The fact that IB-MECA, a A3AR-specific agonist, had theshown to act as the sole PI3K isoform downstream of
same potency as adenosine to stimulate BMMC, suggestsGPCRs in neutrophils and macrophages (Hirsch et al.,
that adenosine activates PI3K solely via the A3AR in mu-2000). Presently, there are no data available that would
rine mast cells. This is in agreement with the observationplace PI3K downstream of a protein tyrosine kinase
that in BMMC with a disrupted A3AR gene, adenosine andcascade initiated by FcRI. This view is in agreement
inosine fail to trigger potentiation of allergen-inducedwith our data, which indicate the existence of an auto-
degranulation (Tilley et al., 2000) and that A3, but not A1crine activation loop initiated by submaximal mast cell
or A2a, agonists activated PKB (Gao et al., 2001).activation and degranulation-liberating GPCR agonists.
We found that chemokines, e.g., RANTES and MIP-1,While the exact composition of the released mediators
as well as other GPCR agonists like ATP, ADP, inosine,is complex and unknown in detail (Barnes et al., 1998),
and LPA, were capable of augmenting antigen-induced
calcium influx and mast cell granule release in a PI3K-
dependent fashion. B. pertussis toxin eliminated bothTable 1. Mast Cells in Tissues of Wild-Type and PI3K/ Mice
costimulatory activities and PKB activation and inter-
Organa Wild-Type PI3K/ fered with the calcium release from internal stores in-
Ear 195.2 
 16.1 221.4 
 17.1 duced by these agonists (data not shown). PAF did not
Skin 97.5 
 16.4 80.0 
 20.9 activate PKB and triggered calcium release from internal
Tongue 17.0 
 3.5 17.9 
 5.1 stores by B. pertussis toxin-insensitive Gq proteins and
a Numbers represent toluidine blue-positive mast cells per square was not able to provide costimulatory signals. The pat-
millimeter and were assayed after tissue fixation in 4% paraformal- tern emerging from these data suggests that receptors
dehyde/PBS and subsequent paraffin embedding as described in coupled to Gi proteins activate PI3K and provide a
(Tilley et al., 2000). Mean 
 SD from three mice.
mandatory pulse of PtdIns(3,4,5)P3 to trigger maximal
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mast cell activation. Distinct and multiple chemokine kine-mediated neutrophil recruitment was also con-
signals can thus be integrated by PI3K. firmed in mast cell-deficient mice (W/Wv mice) (Zhang
The prominent role of PI3K in the activation of mast et al., 1995; Biedermann et al., 2000). Other cell types
cells in vitro was paralleled by diminished responses of expressing high-affinity FcRI receptors, like Langer-
PI3K null mice in mast cell-dependent models in vivo. hans cells (Bieber et al., 1992), eosinophils (Gounni et
When injected intradermally in wild-type mice, adeno- al., 1994), and basophils (Brunner et al., 1993) could
sine displays dramatic effects on vascular permeability contribute to a minor extent to the phenotype of PI3K
and causes edema. The primary target of adenosine in null mice.
the tissue is the A3AR on mast cells, as mice lacking Through its role as an amplifier of mast cell activation,
mast cells or A3AR do not display any increased vascular PI3K takes a central role in the modulation of inflamma-
leakage (Tilley et al., 2000). In accordance with these tion and allergy. It might therefore provide a key to thera-
studies and the results above, adenosine failed to in- peutically controlling some allergic and chronic inflam-
duce edema in PI3K null mice. This suggests that the matory diseases.
lack of PI3Keliminates the mast cell stimulatory actions
Experimental Proceduresof adenosine in vivo completely, while inhibitory signals
via A2aAR and Gq are intact (Forsythe and Ennis, 1999).
AnimalsAs discussed above, activation of mast cells by FcRI
PI3K-deficient mice were generated previously (Hirsch et al., 2000)cross-linking was affected by the loss of PI3K only and were on a 129sv inbred genetic background. PI3K/ animals
indirectly through lack of autocrine stimulation. When and wild-type controls were always age matched and 6- to 10-
mice where challenged in a model for passive systemic weeks old. Further experiments were performed with littermates
and 129ola, yielding identical results. Experiments were carried outanaphylaxis, however, vascular permeability was in-
in accordance with institutional guidelines and national legislation.creased in wild-type, but not in PI3K/ animals. In this
respect, it is interesting to note that A3AR-deficient mice
Bone Marrow Isolation and Mast Cell Differentiationdid perform as wild-type animals in this model (Tilley et
Murine bone marrow cells were cultured at 2 106 cells/ml in IMDMal., 2000). Assuming that the A3AR is the main relay of supplemented with 10% heat-inactivated fetal calf serum, 50 M
adenosine signaling in mast cells, this discrepancy sug- -mercaptoethanol, 290g/ml L-glutamine, 100 g/ml of each peni-
gests that other GPCR ligands besides adenosine play a cillin and streptomycin, and 2 ng/ml recombinant murine IL-3 (R&D
Systems, Minneapolis, MN) at 37C, 5% CO2. IL-3 was readded atpertinent role in passive systemic anaphylaxis and that
3 day intervals and cells were diluted weekly to 0.5  106 cells/mlPI3K is necessary to process these signals in vivo. It
with a mixture of 80% fresh and 20% used medium.has indeed been shown that various chemokines can
cause mast cell activation in vitro and in vivo (Alam et
Flow Cytometryal., 1992, 1994; Conti et al., 1995). Moreover, mast cells
Expression of FcRI in BMMC was performed after the blockage
themselves and surrounding tissues release a plethora of Fc receptors with 2.4G2 rat anti-mouse FcRII/RIII antibody
of mediators and chemokines (Moller et al., 1993; Selvan (Pharmingen, San Diego, CA), followed by individual incubations
et al., 1994), which accumulate in allergic and inflamma- with mouse IgE- (clone NPE7, Sigma, St. Louis, MO) and FITC-
labeled monoclonal rat anti-mouse IgE antibody (IgG1, Phar-tory disease (Alam et al., 1996; Luster and Rothenberg,
mingen, San Diego, CA). For c-Kit expression, Fc receptors were1997; Gordon, 2000; Gerard and Rollins, 2001).
blocked as above, and cells were subsequently incubated with PE-Presently, big efforts are being undertaken to inter-
labeled rat anti-c-Kit monoclonal antibody (IgG2b, ImmunoKontact,
cept cell migration and activation in chronic inflamma- Bioggio, Switzerland). Flow cytometry was carried out on a FACScan
tory disease by chemokine antagonists (Proudfoot et Epics XL (BeckmanCoulter, Fullerton, CA).
al., 2000; Owen, 2001). While such a strategy is attractive
because it makes targeting of specific cell populations Release of Histamine-Containing Granules
Release of histamine-containing granules was quantified by the de-possible (for a review see Luster [1998]), it might fail
termination of -hexosaminidase in cell supernatants essentially asbecause of the high redundancy of the ligand repertoire
described (Ozawa et al., 1993). BMMC were incubated with saturat-released during inflammation and ischemia. Targeting of
ing concentrations of anti-DNP-HSA IgE (100 ng/ml) overnight andPI3K, which relays an important branch of chemokine
were resuspended in Pipes-buffered solution (119 mM NaCl, 5 mM
receptor signaling, may provide a valid alternative. The KCL, 5.6 mM glucose, 1 mM CaCl2, 0.4 mM MgCl2, and 25 mM Pipes,
nonisoform-specific PI3K inhibitor wortmannin has al- pH 7.4, with 0.1% bovine serum albumin) at 1  106 cells/ml at
ready been used successfully to block adenosine-medi- 37C. Degranulation was induced usually by 5 ng/ml DNP-HSA
(Sigma) and the indicated agonists. The reaction was stopped afterated bronchoconstriction in atopic rats (Tigani et al.,
20 min, and -hexosaminidase activity was assessed with p-nitro-2000), but displays too high a toxicity. Potential future
phenlyl-N-acetyl--D-glucosaminide, p-NAG (Ozawa et al., 1993).inhibitors that do not interfere with the vital class IA
Results are the percentage of total TritonX-100 releasablePI3Ks involved in metabolic control, but are specific for
-hexosaminidase in whole cells.
PI3K, might thus be of therapeutic value for allergic Where indicated, cells were preincubated for 4 hr with 100 ng/ml
and chronic inflammatory disease. B. pertussis toxin (Sigma) for 1 min with 10 U/ml adenosine deami-
We and others have recently reported that disruption nase (Sigma) or for 15 min with 100 nM of wortmannin (a kind gift
of Sandoz, Basel, Switzerland) at 37C.of the PI3K gene impairs neutrophil and macrophage
migration in vitro and leukocyte invasion of inflammatory
Cytosolic Calcium Concentrationsites in vivo (Hirsch et al., 2000; Sasaki et al., 2000; Li
Cytosolic calcium concentration was assessed with Fura-2 (Gryn-et al., 2000). While the absence of PI3K affects neutro-
kiewicz et al., 1985) with dual excitation at 340 and 380 nm on a
phil and macrophage migration directly, the attenuating Perkin Elmer LS50B fluorescence spectrometer. Anti-DNP-HSA IgE-
effect on mast cell activation might constitute the pri- saturated BMMC (see above) at 5  106 cells/ml were incubated
mary cause for reduced inflammatory responses in for 45 min at RT with 2 M Fura-2-AM (Molecular Probes, Eugene,
OR) in Tyrode’s buffer (112 mM NaCl, 2.7 mM KCl, 0.4 mM NaH2PO4,PI3K null animals. A central role of mast cells in chemo-
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1.6 mM CaCl2, 1 mM MgCl2, 2 mM Glucose, and 10 mM Hepes, pH phatidylinositol 3-kinase inhibitor: the role of phosphatidylinositol
3,4,5-trisphosphate in neutrophil responses. Biochem. J. 296,7.40, with 1% [w/v] BSA). Emission at 510 nm was measured in
loaded, stimulated cells (1  106 ) resuspended in Tyrode’s every 297–301.
200 ms. Barker, S.A., Caldwell, K.K., Hall, A., Martinez, A.M., Pfeiffer, J.R.,
Oliver, J.M., and Wilson, B.S. (1995). Wortmannin blocks lipid and
Immunoblotting protein kinase activities associated with PI 3-kinase and inhibits a
Proteins were detected in cell lysates from 1  106 BMMC. PKB subset of responses induced by Fc epsilon R1 cross-linking. Mol.
phosphorylated on Ser473 was assayed with an anti-phospho PKB Biol. Cell 6, 1145–1158.
antibody from New England Biolabs (Berverly, MA). Anti-PKB anti-
Barnes, P.J., Chung, K.F., and Page, C.P. (1998). Inflammatory medi-
bodies were a kind gift from B. Hemmings, Basel, Switzerland; anti-
ators of asthma: an update. Pharmacol. Rev. 50, 515–596.
adenosine receptor antibodies (A1AR clone R-18, A2aAR C-19; A2bAR
Bieber, T., de la Salle, H., Wollenberg, A., Hakimi, J., Chizzonite, R.,R-20; and A3AR R-18) were from Santa Cruz Biotech. Inc., Santa
Ring, J., Hanau, D., and de la Salle, C. (1992). Human epidermalCruz, CA; anti-Gi2 (AS 269) and anti-Gi3 (AS 86) were kindly obtained
Langerhans cells express the high affinity receptor for immunoglob-from K. Spicher, Los Angeles, CA. Anti-PI3K antibodies were used
ulin E (Fc epsilon RI). J. Exp. Med. 175, 1285–1290.as described (Hirsch et al., 2000).
Biedermann, T., Kneilling, M., Mailhammer, R., Maier, K., Sander,
Cellular PtdIns(3,4,5)P3 Measurements C.A., Kollias, G., Kunkel, S.L., Hultner, L., and Rocken, M. (2000).
Cellular PtdIns(3,4,5)P3 measurements were performed essentially Mast cells control neutrophil recruitment during T cell-mediated
as described (Arcaro and Wymann, 1993) with some modifications. delayed-type hypersensitivity reactions through tumor necrosis fac-
Briefly, IgE preloaded BMMC were incubated for 2 hr at 1  107 tor and macrophage inflammatory protein 2. J. Exp. Med. 192, 1441–
cells/ml in phosphate-free RPMI 1640/Hepes supplemented with 1452.
2% fetal calf serum before 1 mCi/ml [32Pi]-orthophosphate (carrier- Brunner, T., Heusser, C.H., and Dahinden, C.A. (1993). Human pe-
free, ICN; Costa Mesa, CA) was added for 4 hr at 37C and 5% CO2. ripheral blood basophils primed by interleukin 3 (IL-3) produce IL-4
After stimulation, lipids were extracted, deacylated, and separated in response to immunoglobulin E receptor stimulation. J. Exp. Med.
on HPLC as described (Arcaro and Wymann, 1993). 177, 605–611.
Ching, T.T., Hsu, A.L., Johnson, A.J., and Chen, C.S. (2001). Phos-
Intradermal Injections of Adenosine
phoinositide 3-kinase facilitates antigen-stimulated Ca(2	) influx in
Mice were injected with 100 l of 0.5% Evans blue (Sigma) in apyro-
RBL-2H3 mast cells via a phosphatidylinositol 3,4,5-trisphosphate-
genic 0.9% saline into the tail vein. One hour later, mice were anes-
sensitive Ca(2	) entry mechanism. J. Biol. Chem. 276, 14814–14820.
thetized and were injected with 20 l of adenosine (5  103 M) or
Conti, P., Boucher, W., Letourneau, R., Feliciani, C., Reale, M., Bar-saline into separate ears. One hour after the adenosine injection,
bacane, R.C., Vlagopoulos, P., Bruneau, G., Thibault, J., and Theo-mice were sacrificed and 7 mm ear biopsies were obtained. Evans
harides, T.C. (1995). Monocyte chemotactic protein-1 provokesblue binds to plasma proteins and remains confined to the intravas-
mast cell aggregation and [3H]5HT release. Immunology 86,cular space as long as vascular permeability remains unaltered. The
434–440.accumulation of Evans blue in tissues is thus proportional to the
vascular permeability increase. Evans blue was extracted from the Dombrowicz, D., Flamand, V., Brigman, K.K., Koller, B.H., and Kinet,
tissue in 0.5 ml of formamide at 55C for 48 hr and quantified by J.P. (1993). Abolition of anaphylaxis by targeted disruption of the
absorption at 610 nm. high affinity immunoglobulin E receptor alpha chain gene. Cell 75,
969–976.
Passive Systemic Anaphylaxis Forsythe, P., and Ennis, M. (1999). Adenosine, mast cells and
Mice were injected with 20 g of anti-DNP-HSA IgE (Sigma) in 200 asthma. Inflamm. Res. 48, 301–337.
l of apyrogenic isotonic saline into the tail vein. Passively immu-
Gao, Z., Li, B.S., Day, Y.J., and Linden, J. (2001). A3 adenosinenized mice were challenged by a further tail vein injection with 0.5
receptor activation triggers phosphorylation of protein kinase B andmg of DNP-HSA and 0.5% Evans blue in 200 l of saline. Control
protects rat basophilic leukemia 2H3 mast cells from apoptosis.mice were injected with Evans blue in saline only. To quantify edema
Mol. Pharmacol. 59, 76–82.formation, mice were sacrificed 90 min after the challenge, and
Gerard, C., and Rollins, B.J. (2001). Chemokines and disease. Nat.Evans blue exudation was assayed as above in ear biopsies.
Immunol. 2, 108–115.
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